Rockefeller Capital Management L.P. Immuneering Corp Transaction History
Rockefeller Capital Management L.P.
- $36 Billion
- Q4 2024
A detailed history of Rockefeller Capital Management L.P. transactions in Immuneering Corp stock. As of the latest transaction made, Rockefeller Capital Management L.P. holds 177,377 shares of IMRX stock, worth $296,219. This represents 0.0% of its overall portfolio holdings.
Number of Shares
177,377Holding current value
$296,219% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding IMRX
# of Institutions
44Shares Held
4.59MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.06MShares$1.77 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD767KShares$1.28 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$890,7170.0% of portfolio
-
Morgan Stanley New York, NY454KShares$758,3470.0% of portfolio
-
Southport Management, L.L.C. Wilson, WY215KShares$359,0501.71% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $44.1M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...